PFIZER Aktie

 

Pfizer named 2026 Corporate Champion of Neurodiversity; Colgate-Palmolive's Jesma Johnson and Agency Search Kaizen's Lisa Colantuono honored as Individual Champions NEW YORK CITY, NY / ACCESS Newsw......

Prostate cancer awareness spotlights Pfizer's Xtandi, Novartis' Pluvicto and clinical-stage programs from Candel and Janux....

Pfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure, with established drugs and clinical or regulatory catalysts....

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store....

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the balance sheet leaves almost no room for error. Here is what actually has to hold true for that dividend to survive the next few years....

The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania....

Pfizer has a huge 6% yield and a payout ratio well over 100%, yet the company is still maintaining the dividend....

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

The obesity treatment pipeline is rapidly evolving, with promising candidates such as RGT-075 (Regor Therapeutics), MET-002o (D&D Pharmatech/Pfizer), enicepatide (CT-388; Roche/Carmot Therapeutics), elecoglipron (AstraZeneca), and several other emerging therapies advancing next-generation......

Insight Partners and Medical Excellence Capital led the round, with additional investment from Pfizer Ventures and M Ventures, the corporate venture capital arm of Merck KGaA, all joining The post TwoStep Therapeutics secures $62.5m funding to advance TS-104 appeared first on Pharmaceutical Business review....

Düsseldorf (www.aktiencheck.de) - Pfizer-Chartanalyse von HSBC Trinkaus & Burkhardt: Die Analysten von HSBC Trinkaus & Burkhardt nehmen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) charttechnisch unter die Lupe. Auf der Suche nach eher defensiveren Anlagealternativen sollten sich Anlegerinnen und Anleger die Pfizer-Aktie genauer anschauen. [mehr]...

PFE's non-COVID growth, oncology pipeline and cost cuts offer a path forward as COVID sales fall and patent losses loom....

The beaten-down pharmaceutical stock was revived after it posted an estimates-beating quarter....

Pfizer's 6% dividend yield is enticing, but AbbVie's dividend growth is superior....

The purchase adds an established hypertension brand to Novartis' cardiovascular range. Novartis India's board cleared the deal, after which the company signed an asset purchase agreement and trademark The post Novartis India acquires Pfizer brands for $132m appeared first on Pharmaceutical Business review....

Pfizer's 5.91% dividend yield anchors the story, and a pipeline finally catching a bid adds meaningful upside. My 24/7 Wall St. price target reflects that. Pfizer (NYSE:PFE) trades at $28.77 as of midday September 3, 2026. My 24/7 Wall St. price target is $32.72 over the next 12 months, implying 13.84% upside, with a buy […]...

The pharmaceutical stock is struggling, but its dividend can be highly valuable to income investors....